Cardialen Inc. aims to alter the field of cardiac defibrillation therapy by offering an implant that offers a low-energy shock that could reduce associated mortality issues, as well as eliminate the pain and discomfort that occurs. It is in the middle of a pivotal study of an external device to test its approach and then it plans to develop an implant. Read More
